Novavax says its Covid-19 vaccine is 89.3 percent effective

·

·

Novavax says its Covid-19 vaccine is 89.3 percent effective

Results from Novavax’s Phase 3 trial in the United Kingdom demonstrated the vaccine candidate’s efficacy and showed that it protected against the U.K. variant of the virus. Results from another trial, in South Africa, showed that it was also effective against the …
See Original Article

Home Point cuts offering value to $94 million as it goes public today

Ann Arbor mortgage company reduces offering from $237 million · Private equity ownership still controls vast majority of company · Home Point counts businessman, GOP politico Ron Weiser as investor.
See Original Article

Johnson & Johnson says COVID vaccine was 66% effective in Phase 3 trial

The vaccine also proved 85% effective in preventing severe disease and showed complete protection against COVID-related hospitalization and death as of day 28. The trial involved 43,783 patients and met all of its primary and secondary endpoints.
See Original Article

Charter sees customer growth slow, stock falls after earnings

That beat expectations for earnings per share of $4.83, according to FactSet. Charter generated revenue of $12.6 billion for the quarter, up from $11.7 billion a year earlier and roughly even with the FactSet consensus. The …
See Original Article

3 Credit Card Mistakes I've Made That You Should Avoid

One major benefit of using credit cards is getting to rack up rewards for the purchases you’re already planning to make. But if you let those rewards expire, they won’t be worth anything.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.